Scholarlink

<p>Post-traumatic stress disorder (PTSD) is a severe and chronic psychiatric condition. However, whether PTSD influences tumor immunity remains poorly understood. In this study, we demonstrated that PTSD promotes the growth of subcutaneous transplant tumors in mice, an effect that can be reversed by anti-CD8 antibody treatment. Furthermore, we found that PTSD downregulates serum thiamine levels, which mediates the tumor-promoting effects observed in PTSD mice. In vitro, thiamine enhances CD8<sup>+</sup> T cell activation and cytotoxic function. Mechanistically, thiamine augments tricarboxylic acid (TCA) cycle flux, thereby improving mitochondrial function and energy production, which in turn enhances the anti-tumor activity of CD8<sup>+</sup> T cells. Clinical data corroborated these findings, showing that thiamine supplementation promotes the activation, cytotoxic function, and mitochondrial fitness of peripheral blood mononuclear cell (PBMC)-derived CD8<sup>+</sup> T cells. Our findings highlight the critical role of PTSD-induced thiamine deficiency in impairing tumor-infiltrating CD8<sup>+</sup> T cell function. These results suggest that thiamine supplementation may represent a potential therapeutic strategy to mitigate cancer risk and progression in PTSD patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Post-traumatic stress disorder impairs CD8+ T cell-dependent anti-tumor immune responses by downregulating thiamine

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月8日

查看全文
  • Chaoyun Yin,
  • Conghui Han,
  • Sicheng Wei,
  • Hao Ma,
  • Xiangwei Li,
  • Jianing Xu,
  • Huangao Zhou

摘要

Post-traumatic stress disorder (PTSD) is a severe and chronic psychiatric condition. However, whether PTSD influences tumor immunity remains poorly understood. In this study, we demonstrated that PTSD promotes the growth of subcutaneous transplant tumors in mice, an effect that can be reversed by anti-CD8 antibody treatment. Furthermore, we found that PTSD downregulates serum thiamine levels, which mediates the tumor-promoting effects observed in PTSD mice. In vitro, thiamine enhances CD8+ T cell activation and cytotoxic function. Mechanistically, thiamine augments tricarboxylic acid (TCA) cycle flux, thereby improving mitochondrial function and energy production, which in turn enhances the anti-tumor activity of CD8+ T cells. Clinical data corroborated these findings, showing that thiamine supplementation promotes the activation, cytotoxic function, and mitochondrial fitness of peripheral blood mononuclear cell (PBMC)-derived CD8+ T cells. Our findings highlight the critical role of PTSD-induced thiamine deficiency in impairing tumor-infiltrating CD8+ T cell function. These results suggest that thiamine supplementation may represent a potential therapeutic strategy to mitigate cancer risk and progression in PTSD patients.